Tigecycline treatment in a liver transplant infant with carbapenem-resistant Escherichia coli infection-Reference-Cited by-同舟云学术

Tigecycline treatment in a liver transplant infant with carbapenem-resistant Escherichia coli infection

Published:2019-09 Issue:39 Volume:98 Page:e17339
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Yang Mei,Gao Hengmiao,Wang Xiaoling,Qian Suyun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference18 articles.

1. Tigecycline salvage therapy for necrotizing fasciitis caused by Vibrio vulnificus: case report in a child;Lin;J Microbiol Immunol Infect,2016

2. Successful treatment of multidrug-resistant Escherichia coli bacteremia with tigecycline in an acute myeloid leukemia child;Ozdemir;Turk J Pediatr,2012

3. Experience with tigecycline compassionate use in pediatric patients infected with carbapenem resistant Klebsiella pneumoniae;Hurtado;Rev Chilena Infectol,2012

4. A review of tigecycline—the first, glycylcycline;Peterson;Int Antimicrob Agents,2008

5. The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis;Wang;Ann Clin Microbiol Antimicrob,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world safety profile of tetracyclines in children younger than 8 years old: an analysis of FAERS database and review of case report;Expert Opinion on Drug Safety;2024-05-28

2. Extended‐spectrum β‐lactamase‐producing and carbapenem‐resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches;Transplant Infectious Disease;2022-06-28